# Circulating Tumor Cells Screen for Breast Cancer

> **NCT05633680** · — · UNKNOWN · sponsor: **Handan First Hospital** · enrollment: 200 (estimated)

## Conditions studied

- Breast Neoplasm
- Neoplastic Cells, Circulating

## Interventions

- **DIAGNOSTIC_TEST:** Peripheral blood sampling for circulating tumor cells

## Key facts

- **NCT ID:** NCT05633680
- **Lead sponsor:** Handan First Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-02-20
- **Primary completion:** 2023-04-20
- **Final completion:** 2023-06-20
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2023-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05633680

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05633680, "Circulating Tumor Cells Screen for Breast Cancer". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05633680. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*